• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 的功能突变:对病毒传播、致病性和免疫逃逸的影响。

Functional mutations of SARS-CoV-2: implications to viral transmission, pathogenicity and immune escape.

机构信息

National Health Commission of the People's Republic of China Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

Key Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

出版信息

Chin Med J (Engl). 2022 May 20;135(10):1213-1222. doi: 10.1097/CM9.0000000000002158.

DOI:10.1097/CM9.0000000000002158
PMID:35788093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9337262/
Abstract

The pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to major public health challenges globally. The increasing viral lineages identified indicate that the SARS-CoV-2 genome is evolving at a rapid rate. Viral genomic mutations may cause antigenic drift or shift, which are important ways by which SARS-CoV-2 escapes the human immune system and changes its transmissibility and virulence. Herein, we summarize the functional mutations in SARS-CoV-2 genomes to characterize its adaptive evolution to inform the development of vaccination, treatment as well as control and intervention measures.

摘要

由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的 2019 年冠状病毒病大流行给全球带来了重大的公共卫生挑战。越来越多鉴定出的病毒谱系表明,SARS-CoV-2 基因组正在快速进化。病毒基因组突变可能导致抗原漂移或转变,这是 SARS-CoV-2 逃避人体免疫系统并改变其传染性和毒力的重要方式。在此,我们总结了 SARS-CoV-2 基因组中的功能突变,以描述其适应进化,为疫苗开发、治疗以及控制和干预措施提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afcc/9337262/3ee5ae81c621/cm9-135-1213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afcc/9337262/3ee5ae81c621/cm9-135-1213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afcc/9337262/3ee5ae81c621/cm9-135-1213-g001.jpg

相似文献

1
Functional mutations of SARS-CoV-2: implications to viral transmission, pathogenicity and immune escape.SARS-CoV-2 的功能突变:对病毒传播、致病性和免疫逃逸的影响。
Chin Med J (Engl). 2022 May 20;135(10):1213-1222. doi: 10.1097/CM9.0000000000002158.
2
The Evolution and Biology of SARS-CoV-2 Variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的进化与生物学
Cold Spring Harb Perspect Med. 2022 May 27;12(5):a041390. doi: 10.1101/cshperspect.a041390.
3
B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies.B.1.617.2(德尔塔)变异株:特征、传播及潜在防控策略。
Int J Biol Sci. 2022 Feb 14;18(5):1844-1851. doi: 10.7150/ijbs.66881. eCollection 2022.
4
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
5
The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations.人类微生物群是 SARS-CoV-2 突变的有益储存库。
mBio. 2024 May 8;15(5):e0318723. doi: 10.1128/mbio.03187-23. Epub 2024 Mar 26.
6
Contrasting Distribution of SARS-CoV-2 Lineages across Multiple Rounds of Pandemic Waves in West Bengal, the Gateway of East and North-East States of India.印度东、东北部各州门户的西孟加拉邦在多轮大流行浪潮中,SARS-CoV-2 谱系分布迥异。
Microbiol Spectr. 2022 Aug 31;10(4):e0091422. doi: 10.1128/spectrum.00914-22. Epub 2022 Jul 19.
7
Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.面对神秘突变的愤怒:在新冠肺炎大流行中严重急性呼吸综合征冠状病毒 2 型变体的出现综述。
Environ Microbiol. 2022 Jun;24(6):2615-2629. doi: 10.1111/1462-2920.15687. Epub 2021 Aug 8.
8
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.免疫功能低下宿主接受恢复期血浆治疗后出现多种 SARS-CoV-2 抗体逃逸变异体。
mSphere. 2021 Aug 25;6(4):e0048021. doi: 10.1128/mSphere.00480-21.
9
Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.2021 年 5 月至 2022 年 1 月期间布隆迪严重急性呼吸综合征冠状病毒 2 的基因组监测。
BMC Genomics. 2023 Jun 10;24(1):312. doi: 10.1186/s12864-023-09420-3.
10
Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.对来自土耳其患者的 SARS-CoV-2 分离株进行基因组特征分析显示,刺突蛋白和 nsp12 蛋白存在新型突变。
J Med Virol. 2021 Oct;93(10):6016-6026. doi: 10.1002/jmv.27188. Epub 2021 Jul 16.

引用本文的文献

1
SARS-COV-2 mutations in North Rift, Kenya.肯尼亚北裂谷地区的新冠病毒(SARS-CoV-2)突变
PLoS One. 2025 Jun 6;20(6):e0325133. doi: 10.1371/journal.pone.0325133. eCollection 2025.
2
Biological factors associated with long COVID and comparative analysis of SARS-CoV-2 spike protein variants: a retrospective study in Thailand.与长新冠相关的生物学因素及 SARS-CoV-2 刺突蛋白变异株的比较分析:泰国的一项回顾性研究。
PeerJ. 2024 Aug 19;12:e17898. doi: 10.7717/peerj.17898. eCollection 2024.
3
Impact of mutations on the stability of SARS-CoV-2 nucleocapsid protein structure.

本文引用的文献

1
Recombinant SARS-CoV-2 genomes circulated at low levels over the first year of the pandemic.在疫情的第一年,重组的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组以低水平传播。
Virus Evol. 2021 Jul 15;7(2):veab059. doi: 10.1093/ve/veab059. eCollection 2021 Sep.
2
Assessment of Antibody and T-Cell Responses to the SARS-CoV-2 Virus and Omicron Variant in Unvaccinated Individuals Recovered From COVID-19 Infection in Wuhan, China.评估中国武汉 COVID-19 感染康复未接种疫苗个体对 SARS-CoV-2 病毒和奥密克戎变异株的抗体和 T 细胞反应。
JAMA Netw Open. 2022 Apr 1;5(4):e229199. doi: 10.1001/jamanetworkopen.2022.9199.
3
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
突变对严重急性呼吸综合征冠状病毒2核衣壳蛋白结构稳定性的影响。
Sci Rep. 2024 Mar 11;14(1):5870. doi: 10.1038/s41598-024-55157-8.
4
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium.同源和异源初免-加强免疫接种:对比利时住院COVID-19患者中SARS-CoV-2奥密克戎感染临床严重程度的影响
Vaccines (Basel). 2023 Feb 7;11(2):378. doi: 10.3390/vaccines11020378.
5
Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment.CRISPR-Cas13系统在新冠病毒肺炎诊断与治疗中的研究进展
Genes Dis. 2022 Dec 27;10(6):2414-24. doi: 10.1016/j.gendis.2022.11.016.
COVID-19 康复者感染后 1 年的 SARS-CoV-2 特异性抗体和 T 细胞反应:一项纵向队列研究。
Lancet Microbe. 2022 May;3(5):e348-e356. doi: 10.1016/S2666-5247(22)00036-2. Epub 2022 Mar 23.
4
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 T-Cell Epitopes Identified in COVID-19 Convalescent Individuals.在 COVID-19 康复个体中鉴定的与 SARS-CoV-2 的奥密克戎变异株相关的突变和 CD8 T 细胞表位之间最小交叉。
mBio. 2022 Apr 26;13(2):e0361721. doi: 10.1128/mbio.03617-21. Epub 2022 Mar 1.
5
Bat coronaviruses related to SARS-CoV-2 and infectious for human cells.与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)相关且可感染人类细胞的蝙蝠冠状病毒。
Nature. 2022 Apr;604(7905):330-336. doi: 10.1038/s41586-022-04532-4. Epub 2022 Feb 16.
6
Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.SARS-CoV-2 奥密克戎株感染性和免疫逃避的结构与功能特征。
Cell. 2022 Mar 3;185(5):860-871.e13. doi: 10.1016/j.cell.2022.01.019. Epub 2022 Jan 25.
7
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.新冠病毒奥密克戎改变 TMPRSS2 的使用方式影响其感染性和融合性。
Nature. 2022 Mar;603(7902):706-714. doi: 10.1038/s41586-022-04474-x. Epub 2022 Feb 1.
8
Possible recombination between two variants of concern in a COVID-19 patient.在一名 COVID-19 患者中两种关注变体可能发生重组。
Emerg Microbes Infect. 2022 Dec;11(1):552-555. doi: 10.1080/22221751.2022.2032375.
9
Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer.人类向白尾鹿多次溢出 SARS-CoV-2 并发生传播。
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6). doi: 10.1073/pnas.2121644119.
10
SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody.SARS-CoV-2 奥密克戎刺突糖蛋白受体结合域对 ACE2 表现出超强结合能力,但与恢复期单克隆抗体不结合。
Comput Biol Med. 2022 Mar;142:105226. doi: 10.1016/j.compbiomed.2022.105226. Epub 2022 Jan 7.